Shengjing Tu

Research Areas

COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Antibiotics Pharmacokinetics and Efficacy

Most-Cited Works

• → A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19(2020)5,500 cited